Quick Answer
QIAGEN N.V. reported Stockholders Equity of $3.78 billion for the year ending 2025.
- QIAGEN N.V. showed an increase of +5.9% in Stockholders Equity from 2024 to 2025.
- This data is from QIAGEN N.V.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), QIAGEN N.V.'s Stockholders Equity has grown by 52.6%.
- Historical annual values: Fiscal year 2025: $3.78 billion | Fiscal year 2024: $3.57 billion | Fiscal year 2023: $3.81 billion | Fiscal year 2022: $3.47 billion | Fiscal year 2021: $3.10 billion | Fiscal year 2020: $2.80 billion | Fiscal year 2019: $2.54 billion | Fiscal year 2018: $2.63 billion | Fiscal year 2017: $2.54 billion | Fiscal year 2016: $2.61 billion | Fiscal year 2015: $2.57 billion | Fiscal year 2014: $2.65 billion | Fiscal year 2013: $2.71 billion | Fiscal year 2012: $2.71 billion | Fiscal year 2011: $2.55 billion | Fiscal year 2010: $2.48 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: